A pair of studies published in Diabetologia demonstrate that use of continuous glucose monitors (CGMs) reduces ...

If you've ever had your blood sugar tested, chances are you've heard your doctor mention your A1C. This simple blood test ...

For those with insulin resistance, managing blood sugars is key. While traditional glucose meters require finger pricks, ...

Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.

On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Ex ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device ...

Learn how emerging technologies are enhancing patient engagement and treatment strategies in everyday practice.

GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable ...

How wearables are reshaping chronic disease management with real-time data, personalized treatment, and early intervention ...

Announced U.S. Food and Drug Administration (FDA) approval of VYKAT XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for the treatment of hyperphagia in adults and ...

A new in vitro fertilization benefit would make coverage for up to three attempts to create embryos through an IVF process an ...